((2R,3S,4R,5R)-3,4-Dihydroxy-5-(6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl isobutyrate, 250mg

4-Piperidineethanol>96.0%(GC)(T)25g

2,4,6-Trifluorophenylboronic Acid (contains varying amounts of Anhydride)5g

(5-Amino-1,3-dioxo-1,3-dihydro-isoindol-2-yl)-acetic acid, 250mg

tert-Butyl 6-nitro-1H-indazole-1-carboxylate, 95.0%, 5g

H-D-Arg-NH2.2HCl, 95%, 1g

2-(2-Aminoethylamino)ethanol>99.0%(GC)(T)25mL

(2e)-3-(Quinolin-6-yl)prop-2-enoic acid, 98%, 5g

N-[(4-fluoro-2-methylphenyl)sulfonyl]glycine, 95.0%, 1g

Di-ammonium hydrogen citrate, min. 98%, pa, ACS, 100 g, plastic packaging.

methyl 2-ethoxy-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylate, 97%, 1g

Sodium bisulfite, 58.5%, 1kg

Dialysis membrane Spectra/Por® 7 MWCO 8000, 12 mm, 1 Piece(s)